Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8+ T cells with detection by ELISPOT and HLA-multimer staining

HIV-1-Specific T Cell Precursors with High Proliferative Capacity Correlate with Low Viremia and High CD4 Counts in Untreated Individuals

(2014) Sandra A. Calarota et al.   JOURNAL OF IMMUNOLOGY

Enumeration and Characterization of Human Memory T Cells by Enzyme-Linked Immunospot Assays

(2013) Sandra A. Calarota et al.   Clinical & Developmental Immunology

Detection of Epstein-Barr virus-specific memory CD4+T cells using a peptide-based cultured enzyme-linked immunospot assay

(2013) Sandra A. Calarota et al.   IMMUNOLOGY

Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols

(2012) Helene Filbert et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8+ T-cell responses and increases PSA doubling time

(2012) Lindsey Chudley et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Promiscuous survivin peptide induces robust CD4+ T-cell responses in the majority of vaccinated cancer patients

(2011) Melanie Widenmeyer et al.   INTERNATIONAL JOURNAL OF CANCER

Serum is not required for ex vivo IFN-γ ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program

(2010) A. Mander et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium

(2009) Cedrik Michael Britten et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Performance of serum-supplemented and serum-free media in IFNγ Elispot Assays for human T cells

(2009) Sylvia Janetzki et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

“MIATA”—Minimal Information about T Cell Assays

(2009) Sylvia Janetzki et al.   IMMUNITY

The relationship between human effector and memory T cells measured byex vivoand cultured ELISPOT following recent and distal priming

(2009) Stephen M. Todryk et al.   IMMUNOLOGY

Identification of Major Factors Influencing ELISpot-Based Monitoring of Cellular Responses to Antigens from Mycobacterium tuberculosis

(2009) Steven G. Smith et al.   PLoS One

Fit for purpose? A case study: validation of immunological endpoint assays for the detection of cellular and humoral responses to anti-tumour DNA fusion vaccines

(2008) Ann Mander et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Concordant Proficiency in Measurement of T-Cell Immunity in Human Immunodeficiency Virus Vaccine Clinical Trials by Peripheral Blood Mononuclear Cell and Enzyme-Linked Immunospot Assays in Laboratories from Three Continents

(2008) M. J. Boaz et al.   Clinical and Vaccine Immunology